@article{Hao2026, 
author = {Lijun Hao and Ye Ge and Tingting Wang and Guangji Wang and Jingwei Zhang},
title = {Organ-on-a-chip in natural product research: advancing translational ADME, efficacy and safety assessment},
year = {2026},
journal = {Chinese Journal of Natural Medicines},
volume = {24},
number = {12},
pages = {1431-1443},
keywords = {Organ-on-a-chip, Natural products, ADME, Efficacy, Toxicity, Disease models, Multi-organ systems},
url = {https://www.sciopen.com/article/10.1016/S1875-5364(26)61231-9},
doi = {10.1016/S1875-5364(26)61231-9},
abstract = {Natural products exhibit complex in vivo behaviors governed by dynamic exposure, multi-target interactions, and inter-organ crosstalk, which conventional preclinical models often fail to capture. Organ-on-a-chip (OOC) technologies provide human-relevant in vitro platforms that integrate physiological flow, tissue architecture, and multicellular interactions. This review systematically summarizes recent advances in gut, liver, and multi-organ chip systems for investigating key processes underlying the absorption, metabolism, and systemic exposure of natural products. We further highlight the application of disease-specific OOC models in evaluating pharmacological responses under pathophysiological conditions and assessing organ-specific and immune-related safety risks of natural products. Finally, we discuss current challenges and future directions for OOC-based natural product research, including prioritizing functional biomarker-based standardization, incorporating patient-specific cell sources, engineering systems tailored to the complexity of natural products, and exploring emerging research frontiers, all anchored in mechanistic in vitro-in vivo extrapolation (IVIVE) and quantitative systems pharmacology frameworks toward predictive Digital Twins. Collectively, OOC platforms provide a systematic and translational framework for studying the complex pharmacokinetics and biological effects of natural products.}
}